Readmission Risk Prediction Model for Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis

Jing Liu1, Ping Liu1, Mei-Rong Lei1

  • 1College of Nursing and Rehabilitation, Shandong University, 44 Wenhua Xi Lu, Lixia District, Jinan City, Shandong Province, China.

Insights

This review evaluates risk models for predicting heart failure readmissions. Key predictors include BNP, renal insufficiency, and prior hospitalizations, improving model accuracy.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Health Services Research

Background:

  • Heart failure (CHF) readmissions pose a significant clinical and economic burden.
  • Accurate risk prediction models are crucial for managing CHF patients and reducing readmissions.
  • Existing models require systematic evaluation to assess their predictive performance.

Purpose of the Study:

  • To systematically review and meta-analyze existing risk prediction models for CHF patient readmission.
  • To identify the most effective predictors for CHF readmission risk.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (PubMed, Embase, Web of Science, etc.) up to July 2021.
  • Nine studies (2 prospective, 7 retrospective) met the selection criteria.
  • Study quality was assessed using the CHARMS checklist, and prediction models were systematically evaluated.

Main Results:

  • All evaluated models demonstrated predictive capability with an area under the receiver operating characteristic curve > 0.63.
  • Commonly identified predictors included B-type natriuretic peptide (BNP) or N-terminal pro-brain BNP (OR 4.35), renal insufficiency (OR 1.60), comorbidities, and prior hospitalization history.
  • The predictive accuracy of models was enhanced by non-parametric statistical methods and large electronic datasets.

Conclusions:

  • Risk prediction models for CHF readmission show promise, with specific biomarkers and clinical factors being significant predictors.
  • Calibration and external validation are essential for clinical implementation of these models.
  • Combining parametric and non-parametric methods may lead to more precise predictive models for clinical use.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
44
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
488
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
70